
Sign up to receive Peter's email newsletter: https://bit.ly/4c602k2 Original release date: 8/20/2018 Matt is someone who is deeply interested in understanding the biology of aging. Why do we age? What happens to us as we age? What are the things we can do to slow the aging process? How can we delay or prevent the onset of age-related diseases? These are all questions that Matt thinks deeply about, and explores these questions with his research at the University of Washington. He is currently investigating many of these questions through the Dog Aging Project and the compound rapamycin—the only known pharmacological agent to extend lifespan all the way from yeast to mammals—across a billion years of evolution. We talk about cancer, heart disease, Alzheimer’s disease, healthspan, lifespan, and what we can do to provide longer, healthier lives for both people and dogs. We discuss: -Matt’s early years and his aha moment on aging [4:00]; -Studying dogs [6:30]; -Dogs, rapamycin, and its effects on lifespan and healthspan [15:30]; -An unexpected finding in presumably healthy dogs [36:00]; -Rapamycin in cancer treatment [50:00]; -Why isn’t there a rapamycin trial for Alzheimer’s disease (AD)? [1:01:30]; -If Matt could do a definitive study on life extension in dogs, with resources not being a concern, what does that experiment look like? [1:16:00]; and -More. Show notes page: https://peterattiamd.com/mattkaeberlein/ About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 10 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is the founder of Attia Medical, PC, a medical practice with offices in San Diego and New York City, focusing on the applied science of longevity. The practice applies nutritional biochemistry, exercise physiology, sleep physiology, techniques to increase distress tolerance, lipidology, pharmacology, and four-system endocrinology to increase lifespan (delaying the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com/ Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Play: http://bit.ly/TheDriveGooglePlay

333 ‒ Longevity roundtable—the science of aging, geroprotective molecules, & lifestyle interventions

272 ‒ Rapamycin: potential longevity benefits, surge in popularity, unanswered questions, and more

222 ‒ How nutrition impacts longevity | Matt Kaeberlein, Ph.D.

The Life-Extension Episode With Dr. Matt Kaeberlein | The Tim Ferriss Show

175 - The biology of aging, rapamycin, and other interventions that target the aging process

175 - The biology of aging, rapamycin, and other interventions that target the aging process

272 ‒ Rapamycin: potential longevity benefits, surge in popularity, unanswered questions, and more

Supplements for Longevity & Their Efficacy | Dr. Peter Attia

333 ‒ Longevity roundtable—the science of aging, geroprotective molecules, & lifestyle interventions

171- Longevity science: caloric restriction studies, aging biomarkers & possible longevity molecules